Disparities in incidence and mortality of pediatric acute lymphoblastic leukemia across countries with different incomes

Nan Zhang,Diguang Wen,Teng Wang,Jianchuan Deng
DOI: https://doi.org/10.1038/s41375-024-02433-1
2024-10-05
Leukemia
Abstract:We were interested in the recent study by Rujkijyanont and Inaba that examines the challenges in diagnosing and treating pediatric acute lymphoblastic leukemia (ALL) in low- and middle-income countries [1]. The study indicates that limited resources in low- and middle-income countries lead to suboptimal outcomes compared to high-income countries, where advances in diagnostics and treatment have markedly improved survival rates [1]. These findings underscore the disparities in ALL management and outcomes across different income levels. Recent research and data indicate that global efforts to prevent and treat pediatric ALL still require increased attention to resource allocation and healthcare inequities [2]. Inspired by their research, we conducted our own analysis using Global Burden of Disease data [3]. We employed the Estimated Annual Percentage Change (EAPC) to assess trends from 1990 to 2021, focusing on the disparities in ALL incidence and mortality among children aged 0–14 across countries with different income levels [4]. Our supplementary analysis aims to provide deeper insights into these disparities and contribute to the ongoing discussion on improving global treatment outcomes for pediatric ALL.
oncology,hematology
What problem does this paper attempt to address?